Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection
US8227440B2 · kind B2 · utility
3Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2009 |
| Grant date | Jul 24, 2012 |
| Priority date | — |
| Expiry date | Nov 11, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to therapeutic use of Myxoma virus. Myxomas virus can selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon and can be used to treat diseases characterized by the presence of such cells, including cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.